NON-DISPOSAL UNDERTAKINGNon-Disposal Undertaking • February 8th, 2012 • Cadista Holdings Inc. • Pharmaceutical preparations
We at Cadista Holdings Inc. (the Parent Company), a Delaware corporation with a principal office at 207 Kiley Drive, Salisbury, Maryland 21801, refer to the Credit Facility Agreement dated as of the date hereof (Facility Agreement) entered into between Jubilant Cadista Pharmaceuticals Inc. (Borrower) a Delaware corporation and wholly-owned subsidiary of the Parent Company having its principal office at 207 Kiley Drive, Salisbury, Maryland 21801, and ICICI Bank, New York Branch (hereinafter referred to as either the “Lender”, “Bank” or “you”), under the terms of which you have agreed to provide a revolving credit facility and certain other facilities in an amount not exceeding $ 8,500,000 in the aggregate (Facility) to the Borrower.
